Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer

Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer

Background. The tyrosine kinase inhibitors (TKIs) are indicated for the treatment of locally advanced or metastatic progressive thyroid carcinoma (CDT), refractory to radioactive iodine. The following report describes the efficacy of lenvatinib administered through a nose-gastric tube (SNG) in a pat...

Full description

Bibliographic Details
Main Authors: Eleonora Molinaro, David Viola, Nicola Viola, Pierpaolo Falcetta, Francesca Orsolini, Liborio Torregrossa, Paola Vagli, Alessandro Ribechini, Gabriele Materazzi, Paolo Vitti, Rossella Elisei
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2019/6831237

Internet

http://dx.doi.org/10.1155/2019/6831237

Similar Items